Atlanta, GA1 Active Studies

Clostridioides Difficile Infection Clinical Trials in Atlanta, GA

Find 1 actively recruiting clostridioides difficile infection clinical trials in Atlanta, GA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
60
Enrolling

Recruiting Clostridioides Difficile Infection Studies in Atlanta

About Clostridioides Difficile Infection Clinical Trials in Atlanta

Clostridioides difficile infection is a bacterial infection that causes inflammation of the colon, often following antibiotic use. It can cause severe diarrhea and life-threatening colitis. Treatment includes specific antibiotics, and fecal microbiota transplantation for recurrent cases.

There are currently 1 clostridioides difficile infection clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 60 participants. Research is being sponsored by Bactolife A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.

Clostridioides Difficile Infection Clinical Trials in Atlanta — FAQ

Are there clostridioides difficile infection clinical trials in Atlanta?

Yes, there are 1 clostridioides difficile infection clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What clostridioides difficile infection treatments are being tested?

The 1 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for clostridioides difficile infection.

Data updated July 14, 2026 from ClinicalTrials.gov